Tag: biosimilars vs generics
Biosimilars are billed differently than generics under Medicare Part B. Each has its own HCPCS code and payment rate based on its ASP plus 6% of the reference product’s price. This system encourages biosimilar entry but doesn’t strongly incentivize switching. Learn how billing works and why adoption remains low in the U.S.
Medications
Archives
Recent-posts
Breastfeeding Medication Timing: How to Reduce Infant Drug Exposure
Dec, 4 2025
Transform Your Diet with Chervil – The Ultimate Natural Dietary Supplement
Sep, 4 2023
Coumadin: How This Classic Blood Thinner Impacts Your Health and Daily Life
May, 23 2025
Crossover Trial Design: How Bioequivalence Studies Are Structured
Dec, 15 2025
Indian Generic Manufacturers: The World's Pharmacy and Global Exports
Jan, 26 2026